The Monologue
In April 2022, with the building still under construction, 1333 Broadway LLC closed a three-instrument financing package at 1325 Broadway in Brooklyn's Bushwick-adjacent corridor: a $34.53M first mortgage from Santander Bank, N.A., a $2.97M second mortgage, and an $11.30M agreement recorded the same day. That's nearly $48.8M in debt commitments against a site the LLC had purchased in December 2019 for $16.70M. The land doubled in paper value before a single floor was poured.
The 20-story, 109-unit elevator apartment building that opened in 2023 is now assessed at $4.52M — implying a market value around $10.05M by the city's own ratio — while carrying a capital stack built on a pre-completion appraisal that assumed a very different interest rate environment. That gap is the story. What this building reveals about the 2023-2025 Brooklyn multifamily market is less about what got built and more about what the debt requires next.
The Architecture of 1325 Broadway
At 120,403 square feet on a 32,440-square-foot lot, 1325 Broadway posts a built FAR of 3.71 against a maximum allowable FAR of 2.43 under its R6 zoning — meaning the building is roughly 53% larger than the zoning envelope permits as-of-right. That figure demands explanation. In R6 districts, inclusionary housing bonuses and quality housing program provisions can push effective FAR materially above the base number, and a project of this density almost certainly relied on those mechanisms. The presence of 107 residential units alongside 21,807 square feet of retail and 7,553 square feet of office space suggests a mixed-income program was baked into the entitlement from day one. Affordable set-asides that unlocked the density bonus are now, by design, long-term rent constraints on a meaningful portion of the residential income stream.
The building's program reflects its moment: a 2023 completion means design decisions locked in around 2019 to 2020, when Brooklyn mixed-use rental development was still being underwritten on aggressive rent growth assumptions. The 7,485 square feet of garage space is a period artifact — structured parking made financial sense before remote work hollowed out commuter patterns and before the city's congestion pricing conversation reframed car ownership in outer-borough underwriting. That garage now competes with street parking in a neighborhood where demand for structured spaces has softened, and it represents roughly 6% of the building's footprint generating returns below any reasonable residential or retail alternative.
The Capital Stack: Brooklyn Elevator Markets, 2025–2026
City records show three instruments filed against 1325 Broadway in April 2022, all with Santander Bank, N.A. as lender: a $34.53M mortgage, a $2.97M mortgage, and an $11.30M agreement, totaling $48.8M in debt commitments on a site acquired for $16.70M in December 2019. The construction loan was structured during a window when 10-year Treasuries sat below 2.5% and Brooklyn multifamily cap rates were being underwritten in the mid-4% range. Neither condition holds today. At a stabilized 5.5% cap rate — conservative for this submarket in 2025 — the building needs to generate roughly $2.68M in net operating income annually just to justify a $48.8M valuation. With 107 units averaging somewhere between market and affordable rents in an R6 mixed-income structure, hitting that NOI requires near-full occupancy and retail absorption that hasn't materialized uniformly across Brooklyn's 2022-2023 delivery pipeline.
The assessed value of $4.52M — implying roughly $10.05M in market value by the city's 45% residential assessment ratio — is not a reliable proxy for actual value, but the delta between that figure and the $48.8M debt load is a signal worth reading carefully. Construction loans of this vintage typically carried 3- to 5-year terms, which places a refinancing or recapitalization event somewhere between 2025 and 2027. Santander's appetite for rolling a stabilizing Brooklyn mixed-use asset at current rates is an open question. The sponsor's equity position, measured against a construction cost that almost certainly exceeded $100M for a 120,000-square-foot 20-story tower in New York, is under real pressure. The $16.70M land basis looks efficient in retrospect; the timing of the construction draw schedule does not.
The Light Tower Thesis
The conventional read on 1325 Broadway is that it's a newly delivered, fully entitled, mixed-use multifamily asset in a Brooklyn submarket with long-term demographic tailwinds — a stabilization story that just needs time. That read is incomplete. The building is carrying a construction-era capital stack into a refinancing environment that will require either a material rate concession from Santander, a recapitalization with fresh equity, or a sale at a price that doesn't fully recover the all-in development cost. The inclusionary housing component that enabled the density bonus is not a liability in itself — it's a permanent feature of the income stream that any incoming capital partner will need to model carefully, not paper over with a pro forma growth rate.
A sponsor navigating this asset in 2025 needs a capital advisor who can run the refinancing and recapitalization scenarios simultaneously, stress-test the retail lease-up assumptions against current Brooklyn submarket absorption data, and structure a conversation with Santander before the loan reaches its maturity trigger — not after. The window to get ahead of that conversation is narrowing.